References
- 1. Criqui MH. Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. Am J Cardiol. 2001;88(7B):43J-47J.10.1016/S0002-9149(01)01881-1
- 2. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States:results from the National Health and Nutrition Examination Survey, 1999e2000. Circulation. 2004;110(6):738-743.10.1161/01.CIR.0000137913.26087.F0
- 3. Anderson JL, Jonathan LH, Albert N al. Management of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations). J Am Coll Cardiol. 2013;61(14):1555–1570. doi:10.1016/j.jacc.2013.01.004.10.1016/j.jacc.2013.01.004
- 4. Adam DJ, Beard JD, Cleveland T, et al. BASIL trial participants. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomized controlled trial. Lancet. 2005;366:1925-1934.10.1016/S0140-6736(05)67704-5
- 5. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society consensus for the management of peripheral arterial disease. Int Angiol. 2007;26:81-157.
- 6. Kechagias A, Perälä J, Ylönen K, Mahar MA, Biancari F. Validation of the Finnvasc score in infrainguinal percutaneous transluminal angioplasty for critical lower limb ischemia. Ann Vasc Surg. 2008;22:547-551. doi: 10.1016/j.avsg.2008.01.007.10.1016/j.avsg.2008.01.00718387781
- 7. Schanzer A, Goodney PP, Li Y, et al. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg. 2009;50(4):769-775. doi: 10.1016/j.jvs.2009.05.055.10.1016/j.jvs.2009.05.05519628361
- 8. Arvela E, Söderström M, Korhonen M, et al. Finnvasc score and modified Prevent III score predict long-term. J Vasc Surg 2010;52:1218-1225. doi: 10.1016/j.jvs.2010.06.101.10.1016/j.jvs.2010.06.10120709482
- 9. Levey AS, Stevens LA, Schmid CH, et al. A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150(9):604-612.10.7326/0003-4819-150-9-200905050-00006276356419414839
- 10. Trejo JMR, Sanchez IE, Ramirez NR, et al. Surgery for the rescue of critical limb ischemia. Rev Mex Angiol. 2008;36(3):88–97.
- 11. Belkin M. Secondary bypass after infrainguinal bypass graft failure. Semin Vasc Surg. 2009;22(4):234-239. doi: 10.1053/j.semvascsurg.2009.10.005.10.1053/j.semvascsurg.2009.10.00520006803
- 12. Slovut DP, Sullivan TM. Critical limb ischemia: medical and surgical management. Vasc Med. 2008;13:281–291. doi: 10.1177/1358863X08091485.10.1177/1358863X0809148518687766
- 13. Schanzer A, Hevelone N, Owens CD, et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg. 2007;46:1180-1190. DOI: 10.1016/j.jvs.2007.08.033.10.1016/j.jvs.2007.08.033
- 14. Albäck A, Biancari F, Saarinen O, Lepäntalo M. Prediction of the immediate outcome of femoropopliteal saphenous vein bypass by angiographic runoff score. Eur J Vasc Endovasc Surg. 1998;15:220-224.10.1016/S1078-5884(98)80179-2
- 15. Biancari F, Kantonen I, Albäck A, et al. Limits of infrapopliteal bypass surgery for critical leg ischemia: when not to reconstruct. World J Surg. 2000;24:727-733.10.1007/s002689910117
- 16. Conte MS, Bandyk DF, Clowes AW, et al. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg. 2005;42:456-464.10.1016/j.jvs.2005.05.001
- 17. Arvela E, Söderström M, Albäck A, et al. Estimated glomerular filtration rate (eGFR) as a predictor of outcome after infrainguinal bypass in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2008;36:77-83. doi: 10.1016/j.ejvs.2008.01.018.10.1016/j.ejvs.2008.01.018
- 18. Soga Y, Iida O, Takahaera M, et al. Two-Year Life Expectancy in Patients With Critical Limb Ischemia. J Am Coll Cardiol Intv. 2014;7(12):1444-1449. doi:10.1016/j.jcin.2014.06.018.10.1016/j.jcin.2014.06.018
- 19. Nasr M, McCarthy R, Budd J, Horrocks M. Infrainguinal bypass graft patency and limb salvage rate in CLI: influence of the mode of presentation. Ann Vasc Surg. 2003;17:192-197.10.1007/s10016-001-0257-7
- 20. Luther M, Lepäntalo M. Femorotibial reconstruction for chronic CLI: influence on outcome by diabetes, gender and age. Eur J Vasc Endovasc Surg. 1997;13:569-577.10.1016/S1078-5884(97)80066-4